Final results of the ASG1-3 study, a randomized phase III study comparing a standard dose chemotherapy with epirubicin/cyclophosphamide and paclitaxel with a dose dense regimen with epirubicin and paclitaxelP. A. Fasching,H. Eggemann,J. Krocker,L. Haeberle,B. Volz,A. Kleine-Tebbe,J-U Blohmer,K. Kittel, M. Hufnagel,W. Janni,G. Emons,E. Simon,U. Koehler,C. Thomssen,A. Kohls,M. W. Beckmann,C. Hielscher,P. Krabisch,T. Zeiser,T. Brodkorb,F. Baier,N. Nabieva,S. Kellner,M. Untch, S. Stadie,M. Budner,G-P Breitbach,M. Keller,E. Stickeler,T. Kuehn, M. Tolkmitt,A. K. Belau,M. Schmidt,K. Ulm,S. KuemmelCANCER RESEARCH（2019）引用 1|浏览68AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
